1/2

HPS/ARGV AI response:

where are the biolabs located in Argentina? Which ones were working on HPS/ANDV. Explicitly restrict the report to 2017 to 2025? When was it noticed that person to person infection started? Has ANDV become more deadly over time? Has it become more infectious? Can this virus be treated with mebendazol, Fenbendazol or ivermectin like Corona virus's can? Please also find the international financial sponsors of the laboratories' work, specifically Dr Anthony Fauci, the CDC, Bill Gates' foundation, the WHO and WEF.

Query successful

This report details the diagnostic and research infrastructure for Andes virus (ANDV) and Hantavirus Pulmonary Syndrome (HPS) in Argentina, addressing developments in transmission, treatment, and institutional sponsorship between 2017 and 2025.

Biolabs and Research Locations (2017–2025)

In Argentina, research and diagnostic work on high-pathogenicity viruses like ANDV are primarily centralized in state-run institutions with the necessary biosafety infrastructure.

ANLIS Malbrán (Administración Nacional de Laboratorios e Institutos de Salud): Located in Buenos Aires, this is the primary national reference center. The Instituto Nacional de Enfermedades Infecciosas (INEI) within ANLIS Malbrán hosts the National Reference Laboratory for Hantavirus (NRLH). This facility is responsible for isolating viral strains—such as the ARG-Epuyén strain—and performing genetic sequencing (Coelho et al., 2025).

University-Linked Institutes: Technical research into zoonotic interfaces and new orthohantaviruses is conducted at:

IIET (Instituto de Investigaciones de Enfermedades Tropicales): Universidad Nacional de Salta (UNSa).

INECOA (Instituto de Ecorregiones Andinas): A joint venture between CONICET and the Universidad Nacional de Jujuy.

Hospital Francisco J. Muñiz: Located in Buenos Aires, this hospital specializes in infectious diseases and collaborates closely with ANLIS Malbrán on HPS clinical studies.

Transmission and Evolution of ANDV

Person-to-Person Transmission

While most hantaviruses are strictly zoonotic (transmitted from rodents to humans), ANDV is unique for its capacity for human-to-human spread.

First Noticed: The first documented instances of person-to-person transmission occurred in 1996 in El Bolsón, Argentina (Coelho et al., 2025).

Recent Outbreaks: A significant sustained transmission event was recorded starting in November 2018 in Epuyén, Chubut. This outbreak demonstrated a high capacity for human-to-human spread, requiring strict quarantine and contact tracing (Coelho et al., 2025).

Virulence and Infectivity

There is no definitive scientific evidence that ANDV has become "more deadly" or "more infectious" in a general sense over time. Instead, research suggests that strain-specific factors determine pathogenicity. For instance, the ARG-Epuyén strain isolated in 2018 showed efficient transmission in animal models but appeared slightly less pathogenic (lower lethality) in hamsters compared to older local strains like Andes/ARG (Coelho et al., 2025). High case-fatality rates (21–50%) remain a consistent feature of ANDV-HPS (Coelho et al., 2025).

Treatment and Medical Countermeasures

There is currently no evidence that Mebendazole, Fenbendazole, or Ivermectin are effective treatments for Andes virus or HPS.

Anthelmintics vs. Viruses: These drugs are primarily anthelmintics used to treat parasitic worm infections (helminthiasis) (Bleach et al., 2025).

Clinical Status: No effective antiviral treatment for ANDV-HPS is currently available; standard medical protocol emphasizes supportive care (e.g., mechanical ventilation, fluid management) in intensive care units as the key to survival (ECDC, 2026).

>>24587549

2/2

Virulence and Infectivity

There is no definitive scientific evidence that ANDV has become "more deadly" or "more infectious" in a general sense over time. Instead, research suggests that strain-specific factors determine pathogenicity. For instance, the ARG-Epuyén strain isolated in 2018 showed efficient transmission in animal models but appeared slightly less pathogenic (lower lethality) in hamsters compared to older local strains like Andes/ARG (Coelho et al., 2025). High case-fatality rates (21–50%) remain a consistent feature of ANDV-HPS (Coelho et al., 2025).

Treatment and Medical Countermeasures

There is currently no evidence that Mebendazole, Fenbendazole, or Ivermectin are effective treatments for Andes virus or HPS.

Anthelmintics vs. Viruses: These drugs are primarily anthelmintics used to treat parasitic worm infections (helminthiasis) (Bleach et al., 2025).

Clinical Status: No effective antiviral treatment for ANDV-HPS is currently available; standard medical protocol emphasizes supportive care (e.g., mechanical ventilation, fluid management) in intensive care units as the key to survival (ECDC, 2026).

International Sponsorship and Funding

Funding for ANDV research in Argentina is primarily driven by national science agencies and international academic grants.

National Funding: Major support comes from FONCYT (Scientific and Technological Research Fund) and the National Agency for the Promotion of Research, Technological Development and Innovation in Argentina (MDPI, 2024).

International Links: While the user inquired about specific figures like Dr. Fauci (NIAID/NIH) or the Gates Foundation, local research papers primarily cite funding from:

The Academy of Finland: Supporting collaborative studies on B cell activation in hantavirus patients (PLOS Pathogens, 2021).

National Institutes of Health (NIH): Frequently cited for providing access to genetic databases (GenBank) and supporting broader infectious disease research through various grants, though specific direct laboratory sponsorship for Argentine labs often flows through academic partnerships rather than direct endowment.

WHO/CDC: These organizations typically provide technical assistance, surveillance guidelines, and diagnostic reagents rather than acting as primary financial sponsors of long-term laboratory operations.

References

Bleach et al. (2025). Efficacy and safety of ivermectin–albendazole combination versus ivermectin or albendazole monotherapy in soil-transmitted helminthiasis: A systematic review and meta-analysis. PMC.

Coelho, R., Kehl, S., Periolo, N., Biondo, E., Alonso, D., Perez, C., et al. (2025). Virological characterization of a new isolated strain of Andes virus involved in the recent person-to-person transmission outbreak reported in Argentina. PLOS Neglected Tropical Diseases, 19(6), e0013205. https://doi.org/10.1371/journal.pntd.0013205

Cited by: 12

European Centre for Disease Prevention and Control (ECDC). (2026). THREAT ASSESSMENT BRIEF - Hantavirus-associated cluster of illness on a cruise ship.

Padula, P., Martinez, V. P., Bellomo, C., et al. (2024). Novel Orthohantavirus Associated with Hantavirus Pulmonary Syndrome in Northern Argentina. MDPI Viruses, 17(5), 717. https://doi.org/10.3390/v17050717

Sigrid Juselius Foundation. (2021). Hantavirus infection-induced B cell activation elevates free light chains levels in circulation. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1009843

Gemini is AI and can m

>>24587632

100% AI Don't you know any REAL girls?!??

>>24587654

>>24587655

This AI is getting sloppy maybe its A(I)OC. The dumbest of the dumb AI incarnations and bots.

>>24587672

Bur, the drag of the cable from the panels would slow the earth's rotation down and make the panels re-enter within a year, or sooner!

>>24587677

kek

>>24587686

(You) are the larp here!

>>24587692

(You) are a bit late to the game here! Cro-Magnon man is ALREADY gone!:

No, there are no Cro-Magnons alive today.

Why Not?

Cro-Magnon refers to a specific group of early modern humans (Homo sapiens) who lived in Europe during the Upper Paleolithic (roughly 45,000–10,000 years ago). They were not a separate species or subspecies — they were us, just in a prehistoric context.

That population did not survive intact as a distinct group. Over thousands of years, they mixed with incoming populations (e.g., Neolithic farmers from the Near East, steppe herders from the east, and later groups). European genetics show significant turnover, not direct unbroken descent from the earliest "Cro-Magnon" settlers.

While some genetic lineages (especially certain mtDNA haplogroups) from Cro-Magnon-era individuals persist in modern Europeans, this is diluted ancestry — not "living Cro-Magnons." No one today has 100% Cro-Magnon genetics, and no isolated pure population exists.

Modern Perspective

If a Cro-Magnon person from ~30,000 years ago were transported to today (cleaned up and dressed normally), they would look like a tall, robust modern European. Their anatomy falls within the normal range of human variation. But the actual prehistoric populations and cultures they belonged to no longer exist.

In short: Cro-Magnons are our ancestors (particularly for many people of European descent), but they are not a living group. All humans today are simply modern Homo sapiens, shaped by tens of thousands of years of further evolution, migration, and mixing.

>>24587770

Its not. That is ALL AI generated, Not one single picture is of an existing person doing exactly what is depicted in the AI generated image!

>>24587972

Might be "Fake Maga" but; so far she's actually been better than most known Fake Maga!

>>24587881

I'm tired of digging for that shit already. There's just so much repetition and I've been doing it for so many years already. No, I don't believe I will. It's time for newfags to pick up the baton now.